F.D.A. Approves Pill to Treat Hepatitis C Thor Swift for The New York Times Tom Espinosa, a building inspector in Oakland, Calif, has tried the existing drugs for hepatitis C and some experimental ones, without success. By ANDREW POLLACK Published: December 6, 2013 FACEBOOK TWITTER GOOGLE+ SAVE EMAIL SHARE PRINT REPRINTS The Food and Drug Administration on Friday approved a pill that is expected to make the treatment of hepatitis C less onerous, shorter in duration and more effective. Add to Portfolio Gilead Sciences Inc Go to your Portfolio » The drug, Sovaldi, from Gilead Sciences , will allow at least some patients infected with the liver-destroying virus to be treated with pills only, doing away with weekly injections of a drug that can have debilitating side effects . “Today’s approval represents a significant shift in the treatment paradigm for some patients with chronic hepatitis C,” said ...
Comments
Post a Comment